✦ LIBER ✦

Best practices in the management of toxicities related to anti-EGFR agents for metastatic colorectal cancer

✍ Scribed by Jan Ouwerkerk; Christine Boers-Doets

Book ID: 118435753
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 539 KB
Volume: 14
Category: Article
ISSN: 1462-3889
DOI: 10.1016/j.ejon.2010.03.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of Toxicity Induced by Anti-E

Management of Toxicity Induced by Anti-EGFR Therapy in Metastatic Colorectal Cancer

✍ Christian Rolfo, Giuseppe Bronte, Francesco Passiglia… 📂 Article 📅 2013 🏛 Current Science Inc. 🌐 English ⚖ 290 KB

Effect of low-frequency KRAS mutations o

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer

✍ Tougeron, D.; Lecomte, T.; Pages, J. C.; Villalva, C.; Collin, C.; Ferru, A.; To 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 159 KB

Increased Detection Sensitivity for KRAS

Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer

✍ Molinari, F.; Felicioni, L.; Buscarino, M.; De Dosso, S.; Buttitta, F.; Malatest 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 571 KB

Controversial evaluation of EGFR protein

Controversial evaluation of EGFR protein and gene status in predicting response to anti-EGFR monoclonal antibodies in metastatic colorectal cancer: a case report and review of the literature

✍ Mauro Moroni; Silvio Veronese; Andrea Sartore-Bianchi; Salvatore Artale; Salvato 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 277 KB

PCN15 DIRECT MEDICAL COSTS OF MANAGING T

PCN15 DIRECT MEDICAL COSTS OF MANAGING TOXICITIES RELATED TO TAXANE THERAPY FOR METASTATIC BREAST CANCER IN THE UNITED STATES

✍ TJ Bramley; TT Vishalpura; BS Nightengale 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

A systematic review and meta-analysis of

A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer

✍ Barbara-Ann Adelstein; Timothy A. Dobbins; Carole A. Harris; Ian C. Marschner; R 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 689 KB